Matthew Mimiaga is Professor in the Department of Epidemiology. Fielding School of Public Health, University of California, Los Angeles. His research program focuses on interventions to decrease sexual risk in HIV primary and secondary prevention; biobehavioral interventions to enhance antiretroviral medication uptake and adherence for both HIV treatment (ART) and prevention (PrEP); psychosocial treatment interventions for stimulant use disorder and concurrent HIV risk, and opioid use disorder and adherence to medication-assisted treatment; infectious disease and psychiatric epidemiology; and global health research within 12 resource constrained countries in Asia, Africa, Latin America, and Eastern Europe. His funded studies involve a variety of populations living with, or at risk of acquiring, HIV, such as marginalized and disenfranchised groups with vulnerabilities to health disparities or stigmatized conditions, including sexual and gender minorities, racial/ethnic minorities, and other groups that experience social, political, economic, and/or environmental disadvantage.

To date, Dr. Mimiaga has authored over 325 peer-reviewed, original scientific journal articles in the area of HIV prevention and public health, as well as numerous book chapters and commentaries. Furthermore, he currently is / has been the principal investigator (PI) of several federally funded research grants. These include 15 NIH R-level grants (5 R01s, 4 R21s, 4 R34s, 1 R56, and 1 R03) and 2 CDC U01 grants.